Due to this, FOXM1 serves as a crucial regulator of tumor development, and its overexpression portends a poor prognosis for patients, promoting aggressive tumor phenotype and high resistance to current therapeutic approaches [3, 5]. The gene discussed is FOXM1; the disease is neoplasm.